Freezing juvenile testicular tissue to preserve male fertility
Release time:
2021-11-18
Nowadays, the incidence rate of cancer is getting higher and higher, and it is getting younger and younger. Many people are not yet married and have children, but unfortunately they are suffering from the disease. Because once you suffer from cancer, the use of radiotherapy, chemotherapy and other methods are likely to damage the reproductive organs, affect the production of male or female hormones, and cause the patient to be infertile. In many cases, this infertility is irreversible and affects the patient for life. Frozen reproductive tissue can help patients regain their fertility after recovery.
At present, internationally, the technology of freezing ovarian tissue for female cancer patients is relatively mature. After the disease is cured, it can be transplanted back into the body to preserve their reproductive ability. Many babies have been born with this technology around the world.
However, in comparison, the development of testicular tissue preservation and reimplantation technology has been much slower.
According to a 2020 survey study, institutions that help boys freeze testicular tissue have emerged in the United States, Israel and other regions. The average age of cryopreservers is 7.9 years old. Most of the patients suffer from malignant tumors or blood-related diseases. . However, these institutions can only remove and preserve the testicles, and cannot transplant the testicles back with current technology.
But it's not hopeless.
Back in 2018, scientists conducted experiments with primates, rhesus monkeys. The researchers cut two testicles five months before sexual maturity of the experimental monkey, divided the testicles into small pieces, frozen and freshly preserved them, and then replanted these tissues into the skin of the rhesus monkey's back and scrotum. under.
Fortunately, after only one month, these tissues began to develop, and the testosterone of 80% of the individual rhesus monkeys in the experimental group that grew to adolescence was almost the same as that of normal rhesus monkeys. After 8 to 12 months, these tissues have completely integrated with the surrounding environment, and all of them have seminiferous tubules - a key structure in the testicles where sperm grow and develop.
The initial small piece of testicular tissue develops a variety of cells (left) and sperm (right) that support spermatogenesis.
In the end, 70% of the seminiferous tubules produced mature sperm. The researchers also transplanted the fertilized eggs fertilized by their sperm into female rhesus monkeys and successfully produced them.
Scientists predict that in the next few years, this method will enter the clinical trial stage and help male patients who unfortunately suffered from cancer in childhood. We also look forward to the early realization of this technology to benefit human health.
Latest developments
Over the two days, the symposium was not only a collision of ideas but also seeds sown to advance social progress in life culture. The Shandong Yinfeng Life Science Public Welfare Foundation will continue to use technology as wings and culture as roots, collaborating with all sectors of society to enhance the quality of life for the Chinese people and build a human-centered life care system.
According to recent announcements by the Jinan Municipal Bureau of Science and Technology, 11 outstanding achievements from Jinan have been included in the 2025 "Shandong Outstanding Achievements Report" project. Among them is the globally first-of-its-kind ovarian tissue dual-activation technology developed by Shandong Silver Med Life Science Research Institute (Jinan).
Recently, Frigid Zone Medicine, an authoritative international journal in the field of cryomedicine, published an important review titled "Advances in the Detection Methods for Assessing the Viability of Cryopreserved Samples". Written by the team of Yinfeng Cryomedical Research Center, the article systematically reviews and analyzes various detection techniques currently used to evaluate the viability of cryopreserved cells, tissues, and organs. It also proposes key directions from the perspectives of methodological integration and future instrument development, offering crucial theoretical support and practical guidance for the long - term cryopreservation of complex tissues and organs.
Recently, the "Novel Technology for Ultra-Low Temperature Cryopreservation, Activation, and Transplantation of Human Ovarian Tissue," developed through a collaborative effort between Shandong Yinfeng Life Science Research Institute and Beijing University of Chinese Medicine Shenzhen Hospital, has been awarded the 2025 Shandong Refrigeration and Air Conditioning Science and Technology Award. This groundbreaking technology pioneers a new pathway for female fertility preservation, marking a significant leap in China’s interdisciplinary advancements in reproductive medicine and cryobiology.
On May 19, a delegation from the Chinese Training Workshop for Government Officials of Developing Countries visited the exhibition hall of Yinfeng Biological Group's Cryomedicine Research Center. Government officials from multiple countries gained in-depth insights into Yinfeng’s innovative achievements in cryobiomedicine, cell storage, genetic technology, and other fields. They engaged in discussions with the delegation on technology transfer and international cooperation, contributing to the building of a global community with a shared future for humanity.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
